Sorry, you need to enable JavaScript to visit this website.

CISATRACURIUM BESYLATE (cisatracurium besylate) How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

Cisatracurium besylate injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

Strength NDC No.
(Unit of Sale)
NDC No.
(Each)
Container Carton Configuration
10 mg/5 mL 0409-1098-02 0409-1098-12 5 mL Single-dose Vial 10 Pack
20 mg/10 mL 0409-1208-01 0409-1208-11 10 mL Multiple-dose Vials 10 Pack

NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].

Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:

Strength NDC No.
(Unit of Sale)
NDC No.
(Each)
Container Carton Configuration
200 mg/20 mL 0409-1103-01 0409-1103-11 20 mL Single-dose Vial 10 Pack

Intended only for use in the ICU.

Discard unused portion of the 5 mL and 20 mL single-dose vials.

Storage

Cisatracurium Besylate Injection, USP should be refrigerated at 2° to 8°C (36° to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.

What's New

No Current Announcements.

Contact Pfizer Medical